The FDA granted fast track designation to ATSN-201 for the treatment of X-linked retinoschisis, according to a press release from Atsena Therapeutics.

Neurotech Pharma's cell therapy Encelto has become the first FDA-approved treatment for idiopathic macular telangiectasia ...

Reported $781.4 million in full year 2024 revenues, representing 97% year-over-year growth SYFOVRE® (pegcetacoplan injection) full year 2024 net product revenue of $611.9 millionEMPAVELI® ...

A REDDISH spot can be seen in the centre of the visual field when a white surface is viewed by a normal observer through a dichroic filter transmitting red and blue lights. This phenomenon is ...

Reported $781.4 million in full year 2024 revenues, representing 97% year-over-year growth SYFOVRE® (pegcetacoplan injection) full year 2024 net product revenue of $611.9 millionEMPAVELI® (pegcetacopl ...

In stage I, the vitreous is partially separated from the macula (the part of the retina at the back of your eye) but remains attached to the fovea (the center of the macula). The vitreous is ...

Click the FOLLOW button to be the first to know about this artist's upcoming lots, sold lots, exhibitions and articles ...

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.

Background/ims To compare the retinal vessel diameter measurements obtained from the swept-source optical coherence tomography angiography (OCTA; Plex Elite 9000, Carl Zeiss Meditec, USA) and adaptive ...

Accurate segmentation of large choroidal vessels using optical coherence tomography (OCT) images enables unprecedented quantitative analysis to understand choroidal diseases. In this paper, we propose ...